Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease von Salloway, Stephen, Sperling, Reisa, Fox, Nick C, Blennow, Kaj, Klunk, William, Raskind, Murray, Sabbagh, Marwan, Honig, Lawrence S, Porsteinsson, Anton P, Ferris, Steven, Reichert, Marcel, Ketter, Nzeera, Nejadnik, Bijan, Guenzler, Volkmar, Miloslavsky, Maja, Wang, Daniel, Lu, Yuan, Lull, Julia, Tudor, Iulia Cristina, Liu, Enchi, Grundman, Michael, Yuen, Eric, Black, Ronald, Brashear, H. Robert

Volltext

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis von Sperling, Reisa, Dr, Salloway, Stephen, Prof, Brooks, David J, Prof, Tampieri, Donatella, MD, Barakos, Jerome, MD, Fox, Nick C, Prof, Raskind, Murray, Prof, Sabbagh, Marwan, MD, Honig, Lawrence S, MD, Porsteinsson, Anton P, Prof, Lieberburg, Ivan, MD, Arrighi, H Michael, PhD, Morris, Kristen A, MS, Lu, Yuan, MS, Liu, Enchi, PhD, Gregg, Keith M, PhD, Brashear, H Robert, MD, Kinney, Gene G, PhD, Black, Ronald, MD, Grundman, Michael, MD

Volltext

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup von Sperling, Reisa A, Jack, Clifford R, Black, Sandra E, Frosch, Matthew P, Greenberg, Steven M, Hyman, Bradley T, Scheltens, Philip, Carrillo, Maria C, Thies, William, Bednar, Martin M, Black, Ronald S, Brashear, H. Robert, Grundman, Michael, Siemers, Eric R, Feldman, Howard H, Schindler, Rachel J

Volltext

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial von Sperling, Reisa, Henley, David, Aisen, Paul S, Raman, Rema, Donohue, Michael C, Ernstrom, Karin, Rafii, Michael S, Streffer, Johannes, Shi, Yingqi, Karcher, Keith, Raghavan, Nandini, Tymofyeyev, Yevgen, Bogert, Jennifer, Brashear, H. Robert, Novak, Gerald, Thipphawong, John, Saad, Ziad S, Kolb, Hartmuth, Rofael, Hany, Sanga, Panna, Romano, Gary

Volltext

Safety and efficacy of galantamine in subjects with mild cognitive impairment von WINBLAD, B, GAUTHIER, S, SCINTO, L, FELDMAN, H, WILCOCK, G. K, TRUYEN, L, MAYORGA, A. J, WANG, D, BRASHEAR, H. R, NYE, J. S

Volltext

Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-contro... von Novak, Gerald, Streffer, Johannes Rolf, Timmers, Maarten, Henley, David, Brashear, H. Robert, Bogert, Jennifer, Russu, Alberto, Janssens, Luc, Tesseur, Ina, Tritsmans, Luc, Luc Van Nueten, Engelborghs, Sebastiaan

Volltext

Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials von Vandenberghe, Rik, Rinne, Juha O, Boada, Mercè, Katayama, Sadao, Scheltens, Philip, Vellas, Bruno, Tuchman, Michael, Gass, Achim, Fiebach, Jochen B, Hill, Derek, Lobello, Kasia, Li, David, McRae, Tom, Lucas, Prisca, Evans, Iona, Booth, Kevin, Luscan, Gerald, Wyman, Bradley T, Hua, Lisa, Yang, Lingfeng, Brashear, H Robert, Black, Ronald S

Volltext

The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease von Greenlee, John E., Brashear, H. Robert

Volltext

Comment: Age effects on clinical trial results in Alzheimer dementia von Brashear, H Robert

Volltext

Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis von Arrighi, H Michael, Barakos, Jerome, Barkhof, Frederik, Tampieri, Donatella, Jack, Clifford, Melançon, Denis, Morris, Kristen, Ketter, Nzeera, Liu, Enchi, Brashear, H Robert

Volltext

Galantamine treatment of vascular dementia : A randomized trial von AUCHUS, A. P, BRASHEAR, H. R, SALLOWAY, S, KORCZYN, A. D, DE DEYN, P. P, GASSMANN-MAYER, C

Volltext

Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force von Vellas, Bruno, Carrillo, Maria C, Sampaio, Cristina, Brashear, H. Robert, Siemers, Eric, Hampel, Harald, Schneider, Lon S, Weiner, Michael, Doody, Rachelle, Khachaturian, Zaven, Cedarbaum, Jesse, Grundman, Michael, Broich, Karl, Giacobini, Ezio, Dubois, Bruno, Sperling, Reisa, Wilcock, Gordon K, Fox, Nick, Scheltens, Philip, Touchon, Jacques, Hendrix, Suzanne, Andrieu, Sandrine, Aisen, Paul

Volltext

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Bapineuzumab: A Single‐Ascending‐Dose Study in Patients With Mild to Moderate Alzheimer Disease von Lu, Ming, Brashear, H. Robert

Volltext

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease von Hager, Klaus, Baseman, Alan S, Nye, Jeffrey S, Brashear, H Robert, Han, John, Sano, Mary, Davis, Bonnie, Richards, Henry M

Volltext

Sensitivity of the Preclinical Alzheimer’s Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheime... von Papp, Kathryn V., Rofael, H., Veroff, A. E., Donohue, M. C., Wang, S., Randolph, C., Grober, E., Brashear, H. Robert, Novak, G., Ernstrom, K., Raman, R., Aisen, P. S., Sperling, R., Romano, Gary, Henley, David

Volltext

Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease von Carrillo, Maria C, Brashear, H. Robert, Logovinsky, Veronika, Ryan, J. Michael, Feldman, Howard H, Siemers, Eric R, Abushakra, Susan, Hartley, Dean M, Petersen, Ronald C, Khachaturian, Ara S, Sperling, Reisa A

Volltext

MR imaging features of amyloid-related imaging abnormalities von Barakos, J, Sperling, R, Salloway, S, Jack, C, Gass, A, Fiebach, J B, Tampieri, D, Melançon, D, Miaux, Y, Rippon, G, Black, R, Lu, Y, Brashear, H R, Arrighi, H M, Morris, K A, Grundman, M

Volltext

First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheim... von Delnomdedieu, Marielle, Duvvuri, Sridhar, Li, David Jianjun, Atassi, Nazem, Lu, Ming, Brashear, H Robert, Liu, Enchi, Ness, Seth, Kupiec, James W

Volltext

An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion von Barkhof, F, Daams, M, Scheltens, P, Brashear, H R, Arrighi, H M, Bechten, A, Morris, K, McGovern, M, Wattjes, M P

Volltext

Phase 3 Trials of Solanezumab and Bapineuzumab for Alzheimer's Disease von Laske, Christoph, de la Torre, Jack C, Doody, Rachelle S, Farlow, Martin, Aisen, Paul S, Salloway, Stephen, Sperling, Reisa, Brashear, H. Robert

Volltext